Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Ning Shen Dan Xiang Gao Fang for Heart-Kidney Disharmony Insomnia

The goal of this clinical trial is to learn if Ning Shen Dan Xiang paste combined with Ejiao (donkey-hide gelatin) works better than Ning Shen Dan Xiang paste combined with agar (placebo substitute) to treat chronic insomnia of the heart-kidney disharmony type in adults. It will also assess safety. The main question is: \- Does Ning Shen Dan Xiang + Ejiao improve sleep quality more than the placebo version, as shown by the change in Pittsburgh Sleep Quality Index (PSQI) score after 8 weeks? Researchers will compare the two pastes (identical in appearance and taste except for Ejiao) and use published literature data as an additional external control. Participants will: Take 20 g of the assigned paste twice daily (morning and evening) for 8 weeks. Attend clinic visits at baseline, week 4, week 8, and 1 week after stopping (week 9 follow-up). Complete PSQI and ISI questionnaires, keep a daily electronic sleep diary, provide blood/stool samples, and undergo safety monitoring (blood/urine tests, ECG, vital signs, and side effect checks).

Participants needed: 60
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai 7th People's HospitalUpdated: Apr 1, 2026Locations: 1
Eligibility criteria

Meets the diagnostic criteria for chronic insomnia and simultaneously meets the... [+4]

Pregnant or lactating women. [+8]

Status: Not yet recruiting

Acupuncture and Escitalopram for Treating Major Depression Clinical Study

We will be able to investigate in a sample of patients free of antidepressants whether acupuncture is more effective than placebo.

Participants needed: 216
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai 7th People's HospitalUpdated: Mar 11, 2026Locations: 3
Eligibility criteria

Between 18 and 75 years of age with no gender-based restriction. [+5]

Lifetime or current neuropsychiatric conditions, such as bipolar disorder, schiz... [+7]